{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:23:31Z","timestamp":1785713011835,"version":"3.56.0"},"reference-count":189,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.critrevonc.2008.09.004","type":"journal-article","created":{"date-parts":[[2008,10,26]],"date-time":"2008-10-26T08:16:58Z","timestamp":1225009018000},"page":"235-255","source":"Crossref","is-referenced-by-count":70,"title":["Management of complications of androgen deprivation therapy in the older man"],"prefix":"10.1016","volume":"70","author":[{"given":"Supriya G.","family":"Mohile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Mustian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Bylow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00130404-200511000-00002","article-title":"Population aging and cancer: a cross-national concern","volume":"11","author":"Yancik","year":"2005","journal-title":"Cancer J"},{"issue":"6 Suppl. 1","key":"10.1016\/j.critrevonc.2008.09.004_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2003.10.013","article-title":"Epidemiology of prostate cancer","volume":"62","author":"Crawford","year":"2003","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.critrevonc.2008.09.004_bib4","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2004.10.062","article-title":"The changing face of low-risk prostate cancer: trends in clinical presentation and primary management","volume":"22","author":"Cooperberg","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6 Pt 1","key":"10.1016\/j.critrevonc.2008.09.004_bib5","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.ju.0000127740.96006.1a","article-title":"Changing patterns in competing causes of death in men with prostate cancer: a population based study","volume":"171","author":"Lu-Yao","year":"2004","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jnci\/92.8.613","article-title":"Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort","volume":"92","author":"Newschaffer","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00007611-199007000-00016","article-title":"Prostate carcinoma: an autopsy evaluation of the influence of age, tumor grade, and therapy on tumor biology","volume":"83","author":"Gatling","year":"1990","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/01.ju.0000177470.84735.55","article-title":"Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era","volume":"174","author":"Konety","year":"2005","journal-title":"J Urol"},{"issue":"Suppl 4","key":"10.1016\/j.critrevonc.2008.09.004_bib9","first-page":"S5","article-title":"Prostate cancer: epidemiology and screening","volume":"2","author":"Brawer","year":"2000","journal-title":"Rev Urol"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/0-387-23962-6_1","article-title":"Epidemiology of cancer and aging","volume":"124","author":"Balducci","year":"2005","journal-title":"Cancer Treat Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2006.10.1949","article-title":"Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline","volume":"25","author":"Loblaw","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1078-1439(03)00016-4","article-title":"The timing of hormone therapy for men with asymptomatic advanced prostate cancer","volume":"21","author":"Messing","year":"2003","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib14","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1097-0142(20011101)92:9<2309::AID-CNCR1577>3.0.CO;2-8","article-title":"Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality","volume":"92","author":"Demers","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11912-006-0022-8","article-title":"Management of asymptomatic rise in prostatic-specific antigen in patients with prostate cancer","volume":"8","author":"Mohile","year":"2006","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1097\/01.ju.0000091641.34674.11","article-title":"Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE","volume":"170","author":"Harlan","year":"2003","journal-title":"J Urol"},{"issue":"13","key":"10.1016\/j.critrevonc.2008.09.004_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/95.13.981","article-title":"National practice patterns and time trends in androgen ablation for localized prostate cancer","volume":"95","author":"Cooperberg","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.critrevonc.2008.09.004_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.hoc.2006.03.013","article-title":"Androgen deprivation therapy: monitoring and managing the complications","volume":"20","author":"Higano","year":"2006","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6 Pt 1","key":"10.1016\/j.critrevonc.2008.09.004_bib20","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.juro.2006.07.151","article-title":"Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer","volume":"176","author":"Joly","year":"2006","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib21","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/cncr.23084","article-title":"Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: A conceptual review","volume":"110","author":"Bylow","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.22495","article-title":"A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation","volume":"109","author":"Mohile","year":"2007","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.critrevonc.2008.09.004_bib23","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2004.04.579","article-title":"American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer","volume":"22","author":"Loblaw","year":"2004","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.7326\/0003-4819-132-7-200004040-00009","article-title":"Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis","volume":"132","author":"Seidenfeld","year":"2000","journal-title":"Ann Intern Med"},{"issue":"6 Pt 2","key":"10.1016\/j.critrevonc.2008.09.004_bib25","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/S0022-5347(01)62207-9","article-title":"Cost comparison of orchiectomy and leuprolide in metastatic prostate cancer","volume":"160","author":"Bonzani","year":"1998","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib26","article-title":"Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer","author":"Seidenfeld","year":"1999","journal-title":"Evid Rep Technol Assess (Summ)"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1464-410X.2006.06013.x","article-title":"Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer","volume":"97","author":"Murthy","year":"2006","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.10219","article-title":"Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma","volume":"94","author":"Pickles","year":"2002","journal-title":"Cancer"},{"issue":"1A Suppl.","key":"10.1016\/j.critrevonc.2008.09.004_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0090-4295(96)80007-0","article-title":"A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer","volume":"47","author":"Bales","year":"1996","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.10647","article-title":"Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma","volume":"95","author":"Samson","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib31","first-page":"CD001526","article-title":"Maximal androgen blockade for advanced prostate cancer","author":"Schmitt","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0090-4295(00)01086-4","article-title":"Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review","volume":"57","author":"Schmitt","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib33","doi-asserted-by":"crossref","unstructured":"Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists\u2019 Collaborative Group. Lancet 2000; 355(9214):1491\u20138.","DOI":"10.1016\/S0140-6736(00)02163-2"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2006.06.006","article-title":"Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review","volume":"60","author":"Alibhai","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1464-410X.2002.t01-6-02967.x","article-title":"Hot flushes and prostate cancer: pathogenesis and treatment","volume":"90","author":"Spetz","year":"2002","journal-title":"BJU Int"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007611-199809000-00010","article-title":"Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer","volume":"91","author":"Schow","year":"1998","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib37","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0022-5347(17)32530-2","article-title":"Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma","volume":"152","author":"Karling","year":"1994","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ucl.2005.12.008","article-title":"Managing complications of androgen deprivation therapy for prostate cancer","volume":"33","author":"Holzbeierlein","year":"2006","journal-title":"Urol Clin North Am"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib39","first-page":"263","article-title":"Incidence and management of hot flashes in prostate cancer","volume":"1","author":"Spetz","year":"2003","journal-title":"J Support Oncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.urolonc.2005.03.018","article-title":"Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients","volume":"23","author":"Moyad","year":"2005","journal-title":"Urol Oncol"},{"issue":"4 Suppl. 1","key":"10.1016\/j.critrevonc.2008.09.004_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0090-4295(02)01641-2","article-title":"Complementary\/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women","volume":"59","author":"Moyad","year":"2002","journal-title":"Urology"},{"issue":"2 Suppl. 1","key":"10.1016\/j.critrevonc.2008.09.004_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib43","doi-asserted-by":"crossref","unstructured":"Frisk J, Spetz AC, Hjertberg H, Petersson B, Hammar M. Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer\u2014a prospective multicenter study with long-term follow-up. Eur Urol 2008, doi:10.1016\/j.eururo.2008.02.002.","DOI":"10.1016\/j.eururo.2008.02.002"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/aim.23.4.171","article-title":"Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients\u2014audit and treatment algorithm","volume":"23","author":"Filshie","year":"2005","journal-title":"Acupunct Med"},{"issue":"10","key":"10.1016\/j.critrevonc.2008.09.004_bib45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0029-7844(97)00597-8","article-title":"The effect of dietary soy supplementation on hot flushes","volume":"91","author":"Albertazzi","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2310\/7200.2007.007","article-title":"Pilot evaluation of flaxseed for the management of hot flashes","volume":"5","author":"Pruthi","year":"2007","journal-title":"J Soc Integr Oncol"},{"issue":"11","key":"10.1016\/j.critrevonc.2008.09.004_bib48","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00007611-199904000-00013","article-title":"Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes","volume":"92","author":"Sartor","year":"1999","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0885-3924(03)00043-5","article-title":"Rapid progression of advanced \u201chormone-resistant\u201d prostate cancer during palliative treatment with progestins for cancer cachexia","volume":"25","author":"Tassinari","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.ju.0000165570.28635.4b","article-title":"Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer","volume":"174","author":"Langenstroer","year":"2005","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0090-4295(92)90401-H","article-title":"Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer","volume":"40","author":"Miller","year":"1992","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0090-4295(99)00370-2","article-title":"Transdermal estrogen in the treatment of hot flushes in men with prostate cancer","volume":"55","author":"Gerber","year":"2000","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/gme.0b013e31802e7f22","article-title":"The variable response of women with menopausal hot flashes when treated with sertraline","volume":"14","author":"Kerwin","year":"2007","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.AOG.0000258278.73505.fa","article-title":"Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial","volume":"109","author":"Grady","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-1611(199803\/04)7:2<129::AID-PON294>3.3.CO;2-K","article-title":"Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer","volume":"7","author":"Roth","year":"1998","journal-title":"Psychooncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib59","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","article-title":"Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors","volume":"16","author":"Loprinzi","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00005392-199907000-00024","article-title":"Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer","volume":"162","author":"Quella","year":"1999","journal-title":"J Urol"},{"issue":"9247","key":"10.1016\/j.critrevonc.2008.09.004_bib61","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"issue":"9488","key":"10.1016\/j.critrevonc.2008.09.004_bib62","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib63","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2006.07.5390","article-title":"Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5","volume":"25","author":"Loprinzi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib64","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1464-410X.1997.00234.x","article-title":"Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade","volume":"79","author":"Strum","year":"1997","journal-title":"Br J Urol"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2004.11.008","article-title":"Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery","volume":"62","author":"Chander","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<243::AID-PROS5>3.0.CO;2-C","article-title":"Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy","volume":"29","author":"Asbell","year":"1996","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib67","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/147323000803600101","article-title":"Role of erythropoietin in cancer-related anaemia: a double-edged sword?","volume":"36","author":"Guan","year":"2008","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1743-6109.2006.00245.x","article-title":"Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence","volume":"3","author":"Traish","year":"2006","journal-title":"J Sex Med"},{"issue":"3 Suppl.","key":"10.1016\/j.critrevonc.2008.09.004_bib70","first-page":"76","article-title":"Testosterone, aging and quality of life","volume":"28","author":"Morley","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1442-2042.1999.06128.x","article-title":"Erectile function and nocturnal penile tumescence in patients with prostate cancer undergoing luteinizing hormone-releasing hormone agonist therapy","volume":"6","author":"Marumo","year":"1999","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib72","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.juro.2007.08.007","article-title":"Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer","volume":"178","author":"Teloken","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib73","first-page":"CD005540","article-title":"Interventions for sexual dysfunction following treatments for cancer","author":"Miles","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.critrevonc.2008.09.004_bib74","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/cncr.10970","article-title":"The use of treatments for erectile dysfunction among survivors of prostate carcinoma","volume":"95","author":"Schover","year":"2002","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib75","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.socscimed.2006.08.007","article-title":"The sexuality and social performance of androgen-deprived (castrated) men throughout history: implications for modern day cancer patients","volume":"63","author":"Aucoin","year":"2006","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib76","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1081\/CNV-200039641","article-title":"Facing erectile dysfunction due to prostate cancer treatment: perspectives of men and their partners","volume":"22","author":"Boehmer","year":"2004","journal-title":"Cancer Invest"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib77","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/cncr.21537","article-title":"Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma","volume":"104","author":"Canada","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib78","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jnci\/94.6.430","article-title":"Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy","volume":"94","author":"Potosky","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1464-410X.2004.04902.x","article-title":"Information needs and prostate cancer: the development of a systematic means of identification","volume":"94","author":"Dale","year":"2004","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib80","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pon.592","article-title":"Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study","volume":"11","author":"Pirl","year":"2002","journal-title":"Psychooncology"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib81","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/.465","article-title":"Risk of the \u201candrogen deprivation syndrome\u201d in men receiving androgen deprivation for prostate cancer","volume":"166","author":"Shahinian","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1207\/s15324796abm3103_8","article-title":"A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding","volume":"31","author":"Penedo","year":"2006","journal-title":"Ann Behav Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/cncr.11894","article-title":"Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma","volume":"100","author":"Penedo","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib84","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1464-410X.2002.02917.x","article-title":"Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial","volume":"90","author":"Green","year":"2002","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib85","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1464-410X.2004.04763.x","article-title":"Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial","volume":"93","author":"Green","year":"2004","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2005.05565.x","article-title":"Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study","volume":"96","author":"Jenkins","year":"2005","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib87","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.psyneuen.2003.11.002","article-title":"One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men","volume":"29","author":"Almeida","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib88","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/01.ju.0000091640.59812.83","article-title":"The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer","volume":"170","author":"Cherrier","year":"2003","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib89","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6601235","article-title":"Androgen deprivation and cognition in prostate cancer","volume":"89","author":"Salminen","year":"2003","journal-title":"Br J Cancer"},{"issue":"22","key":"10.1016\/j.critrevonc.2008.09.004_bib90","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1158\/1078-0432.CCR-04-0750","article-title":"Associations between serum testosterone fall and cognitive function in prostate cancer patients","volume":"10","author":"Salminen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1532-5415.2004.52067.x","article-title":"The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer","volume":"52","author":"Taxel","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib92","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-5347(05)00049-2","article-title":"Testosterone loss and estradiol administration modify memory in men","volume":"175","author":"Beer","year":"2006","journal-title":"J Urol."},{"issue":"14","key":"10.1016\/j.critrevonc.2008.09.004_bib93","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.2006.10.2954","article-title":"A practical approach to geriatric assessment in oncology","volume":"25","author":"Rodin","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.critrevonc.2008.09.004_bib94","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","article-title":"A Short Portable Mental Status Questionnaire for the assessment of organic brain deficit in elderly patients","volume":"23","author":"Pfeiffer","year":"1975","journal-title":"J Am Geriatr Soc"},{"issue":"24","key":"10.1016\/j.critrevonc.2008.09.004_bib95","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.23440","article-title":"Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome","author":"Smith","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib97","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.juro.2006.03.057","article-title":"The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters","volume":"176","author":"Yannucci","year":"2006","journal-title":"J Urol"},{"issue":"27","key":"10.1016\/j.critrevonc.2008.09.004_bib98","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.critrevonc.2008.09.004_bib99","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib101","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpuro0995","article-title":"Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?","volume":"5","author":"Higano","year":"2008","journal-title":"Nat Clin Pract Urol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00198-004-1694-2","article-title":"Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures","volume":"16","author":"Orsini","year":"2005","journal-title":"Osteoporos Int"},{"issue":"9156","key":"10.1016\/j.critrevonc.2008.09.004_bib103","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/er.23.3.279","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"issue":"13","key":"10.1016\/j.critrevonc.2008.09.004_bib105","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.2004.01.174","article-title":"Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib106","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urology.2006.11.002","article-title":"Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer","volume":"69","author":"Morote","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2007.03.026","article-title":"Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy","volume":"70","author":"Ryan","year":"2007","journal-title":"Urology"},{"issue":"31","key":"10.1016\/j.critrevonc.2008.09.004_bib108","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib109","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(05)00033-9","article-title":"Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer","volume":"175","author":"Smith","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib111","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-5347(01)65165-6","article-title":"Osteoporosis after orchiectomy for prostate cancer","volume":"157","author":"Daniell","year":"1997","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib112","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/01.ju.0000059281.67667.97","article-title":"Fracture risk following bilateral orchiectomy","volume":"169","author":"Melton","year":"2003","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib113","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies","volume":"100","author":"Diamond","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-129-2-199807150-00002","article-title":"Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group","volume":"129","author":"Gregg","year":"1998","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib115","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2003.09.534","article-title":"Resistance exercise in men receiving androgen deprivation therapy for prostate cancer","volume":"21","author":"Segal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib116","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.urology.2008.03.032","article-title":"Falls and physical performance deficits in older prostate cancer patients on androgen deprivation therapy","volume":"72","author":"Bylow","year":"2008","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMcp020719","article-title":"Clinical practice. Preventing falls in elderly persons","volume":"348","author":"Tinetti","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib118","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0269215507075206","article-title":"Effects of exercise and nutrition on postural balance and risk of falling in elderly people with decreased bone mineral density: randomized controlled trial pilot study","volume":"21","author":"Swanenburg","year":"2007","journal-title":"Clin Rehabil"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.csm.2007.09.002","article-title":"Tai Chi Chuan exercises in enhancing bone mineral density in active seniors","volume":"27","author":"Lui","year":"2008","journal-title":"Clin Sports Med"},{"issue":"10","key":"10.1016\/j.critrevonc.2008.09.004_bib120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.critrevonc.2008.09.004_bib121","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib122","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.ju.0000063820.94994.95","article-title":"Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib123","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.04.078","article-title":"Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer","volume":"176","author":"Ryan","year":"2006","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib124","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2006.07.3361","article-title":"Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer","volume":"25","author":"Michaelson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib126","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-146-6-200703200-00006","article-title":"Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.critrevonc.2008.09.004_bib127","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib128","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2008.09.004_bib129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/theoncologist.10-90001-19","article-title":"Bisphosphonate treatment recommendations for oncologists","volume":"10","author":"von Moos","year":"2005","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib130","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1210\/jc.2003-032058","article-title":"Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib131","first-page":"1567","article-title":"Geriatric syndromes and assessment in older cancer patients","volume":"15","author":"Naeim","year":"2001","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib132","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.20766","article-title":"Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy","volume":"103","author":"Tanvetyanon","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib133","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11606-007-0291-4","article-title":"Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy","volume":"22","author":"Yee","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"5 Pt 2","key":"10.1016\/j.critrevonc.2008.09.004_bib134","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/01.ju.0000141820.17959.2f","article-title":"Osteoporosis and obesity in men receiving hormone therapy for prostate cancer","volume":"172","author":"Smith","year":"2004","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib135","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","article-title":"Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer","volume":"63","author":"Smith","year":"2004","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib136","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib137","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0531-5565(01)00220-0","article-title":"The biochemistry of aging muscle","volume":"37","author":"Carmeli","year":"2002","journal-title":"Exp Gerontol"},{"issue":"8","key":"10.1016\/j.critrevonc.2008.09.004_bib138","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib139","doi-asserted-by":"crossref","first-page":"E366","DOI":"10.1152\/ajpendo.2000.279.2.E366","article-title":"Weight stability masks sarcopenia in elderly men and women","volume":"279","author":"Gallagher","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib140","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0022-5347(05)64985-3","article-title":"Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy","volume":"167","author":"Berruti","year":"2002","journal-title":"J Urol"},{"issue":"3\u20134","key":"10.1016\/j.critrevonc.2008.09.004_bib141","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13685530500361226","article-title":"The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer","volume":"8","author":"Boxer","year":"2005","journal-title":"Aging Male"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib142","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1152\/jappl.1997.83.5.1581","article-title":"Age and gender comparisons of muscle strength in 654 women and men aged 20\u201393 yr","volume":"83","author":"Lindle","year":"1997","journal-title":"J Appl Physiol"},{"issue":"22","key":"10.1016\/j.critrevonc.2008.09.004_bib143","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1001\/jama.263.22.3029","article-title":"High-intensity strength training in nonagenarians. Effects on skeletal muscle","volume":"263","author":"Fiatarone","year":"1990","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib144","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1152\/jappl.1991.71.2.644","article-title":"A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women","volume":"71","author":"Frontera","year":"1991","journal-title":"J Appl Physiol"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients","volume":"56","author":"Basaria","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.critrevonc.2008.09.004_bib146","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2522\/ptj.20060302","article-title":"Physical function in men with prostate cancer on androgen deprivation therapy","volume":"87","author":"Clay","year":"2007","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib147","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.urology.2008.03.032","article-title":"Falls and physical performance deficits in older prostate cancer patients on androgen deprivation therapy","volume":"72","author":"Bylow","year":"2008","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib148","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1532-5415.2004.52416.x","article-title":"Fall-risk assessment and management in clinical practice: views from healthcare providers","volume":"52","author":"Fortinsky","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib149","first-page":"CD004441","article-title":"Population-based interventions for the prevention of fall-related injuries in older people","author":"McClure","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2008.09.004_bib150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J027v25n01_04","article-title":"Evidence-based interventions in fall prevention","volume":"25","author":"Pynoos","year":"2006","journal-title":"Home Health Care Serv Q"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib151","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1249\/01.mss.0000233803.48691.8b","article-title":"Resistance training and reduction of treatment side effects in prostate cancer patients","volume":"38","author":"Galvao","year":"2006","journal-title":"Med Sci Sports Exerc"},{"issue":"17","key":"10.1016\/j.critrevonc.2008.09.004_bib152","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2001.19.17.3750","article-title":"Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study","volume":"19","author":"Potosky","year":"2001","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib153","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.20.2.557","article-title":"Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer","volume":"20","author":"Wei","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib154","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cncr.10656","article-title":"The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma","volume":"95","author":"Fowler","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1532-5415.2005.00567.x","article-title":"Quality of life in prostate cancer patients taking androgen deprivation therapy","volume":"54","author":"Dacal","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib156","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0090-4295(98)00408-7","article-title":"Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE","volume":"53","author":"Lubeck","year":"1999","journal-title":"Urology"},{"issue":"2 Suppl. 1","key":"10.1016\/j.critrevonc.2008.09.004_bib157","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0090-4295(01)01250-X","article-title":"The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer","volume":"58","author":"Lubeck","year":"2001","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib158","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0022-5347(05)67533-7","article-title":"Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy","volume":"163","author":"Herr","year":"2000","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0302-2838(03)00208-2","article-title":"The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer","volume":"44","author":"van Andel","year":"2003","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.juro.2006.08.061","article-title":"Quality of life for men receiving a second treatment for prostate cancer","volume":"177","author":"Arredondo","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib161","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000421-199808000-00002","article-title":"Quality-of-life outcomes in long-term survivors of advanced prostate cancer","volume":"21","author":"Litwin","year":"1998","journal-title":"Am J Clin Oncol"},{"issue":"20","key":"10.1016\/j.critrevonc.2008.09.004_bib162","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/jnci\/90.20.1537","article-title":"Quality of life in advanced prostate cancer: results of a randomized therapeutic trial","volume":"90","author":"Moinpour","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib163","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0022-5347(01)61624-0","article-title":"Health related quality of life in older men without prostate cancer","volume":"161","author":"Litwin","year":"1999","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib164","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.critrevonc.2008.09.004_bib165","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jama.279.15.1187","article-title":"Importance of functional measures in predicting mortality among older hospitalized patients","volume":"279","author":"Inouye","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib166","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-5415.1997.tb00938.x","article-title":"Frailty and hospitalization of long-term stay nursing home residents","volume":"45","author":"Fried","year":"1997","journal-title":"J Am Geriatr Soc"},{"issue":"8878","key":"10.1016\/j.critrevonc.2008.09.004_bib167","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0140-6736(93)92884-V","article-title":"Comprehensive geriatric assessment: a meta-analysis of controlled trials","volume":"342","author":"Stuck","year":"1993","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib168","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0895-4356(94)90178-3","article-title":"Long-term physical functioning in persons with knee osteoarthritis from NHANES. I. Effects of comorbid medical conditions","volume":"47","author":"Ettinger","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.critrevonc.2008.09.004_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0895-4356(98)00124-3","article-title":"Association of comorbidity with disability in older women: the Women\u2019s Health and Aging Study","volume":"52","author":"Fried","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.med.54.101601.152221","article-title":"Standards of care in geriatric practice","volume":"54","author":"Luchi","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2006.03.002","article-title":"Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study Breast cancer treatment: Age and ethnicity","author":"Naeim","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"15","key":"10.1016\/j.critrevonc.2008.09.004_bib172","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1200\/JCO.2005.03.1567","article-title":"Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care","volume":"24","author":"Koroukian","year":"2006","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.critrevonc.2008.09.004_bib173","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1200\/JCO.2005.02.8514","article-title":"Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit","volume":"24","author":"Flood","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib174","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib175","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ctrv.2005.04.012","article-title":"Cancer in the older person","volume":"31","author":"Carreca","year":"2005","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib176","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/107327480301000602","article-title":"Guidelines for the treatment of elderly cancer patients","volume":"10","author":"Lichtman","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib177","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.critrevonc.2008.09.004_bib178","first-page":"609","article-title":"Scales to measure competence in everyday activities","volume":"24","author":"Lawton","year":"1988","journal-title":"Psychopharmacol Bull"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.09.004_bib179","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2008.09.004_bib180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"10.1016\/j.critrevonc.2008.09.004_bib181","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"13","key":"10.1016\/j.critrevonc.2008.09.004_bib182","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","article-title":"Drug-drug interactions among elderly patients hospitalized for drug toxicity","volume":"289","author":"Juurlink","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.004_bib183","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0895-4356(90)90035-N","article-title":"Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents","volume":"43","author":"Fillenbaum","year":"1990","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib184","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A Short Physical Performance Battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"issue":"3","key":"10.1016\/j.critrevonc.2008.09.004_bib185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-Item Health Survey 1.0","volume":"2","author":"Hays","year":"1993","journal-title":"Health Econ"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.09.004_bib186","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","article-title":"The vulnerable elders survey: a tool for identifying vulnerable older people in the community","volume":"49","author":"Saliba","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.critrevonc.2008.09.004_bib187","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1210\/jc.2003-030200","article-title":"Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study","volume":"88","author":"Szulc","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.critrevonc.2008.09.004_bib188","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1040-8428(99)00063-3","article-title":"Management of the frail person with advanced cancer","volume":"33","author":"Balducci","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2008.09.004_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2007.12.006","article-title":"Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program","author":"Basso","year":"2008","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T22:44:55Z","timestamp":1557873895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":189,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1040842808002163"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.09.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}